No Data
Limin's Unit Gets Nod to Set Up Multifunctional Plant in China's Xuzhou City
Limin Group (002734.SZ): Subsidiary obtains investment project filing certificate
On September 18th, Gelonghui announced that Limin Group (002734.SZ) recently announced that its wholly-owned subsidiary, Limin Chemical Co., Ltd. (hereinafter referred to as Limin Chemical), has obtained the "Jiangsu Province Investment Project Filing Certificate" issued by the Xuzhou Industrial and Information Bureau [Filing Certificate No.: Xuzhou Industrial and Information Backup (2024) No. 3], The specific details are as follows: 1. Project name: Annual production of 100 tons of new efficient multifunctional pesticide raw material technology improvement project. 2. Filing approval institution: Xuzhou Industrial and Information Bureau. 3. Project overview: In order to further enhance the company's core competitiveness, it plans to invest in the construction of this project. The project plans to invest 50 million.
limin group (002734.SZ): Currently, the company's API production capacity is 0.1027 million tons, and the formulation production capacity is 0.1144 million tons.
Limin Group (002734.SZ) stated on the investor interaction platform on September 11 that the company has the advantage of a complete industry chain in the field of biologically fermentation, semi-synthetic biology, and formulation processing. It has advanced biologically fermentation technology, chemical synthesis technology, and formulation compatibility technology, which gives it advantages in terms of product cost, quality, and supply. Currently, the company's capacity for raw materials is 0.1027 million tons, and the capacity for formulation is 0.1144 million tons. The capacity utilization rate in 2023 is 68.35% for raw materials and 85.28% for formulations. In the first half of this year, the production of raw materials increased by 16.59% year-on-year, and the production of formulations increased by 19%.
limin group (002734.SZ): Currently, the company's products such as avemycin and methionine are in short supply.
Gelonghui September 11th, limin group (002734.SZ) stated on the investor interaction platform that currently the company's products such as avilamycin and methionine salt are in short supply, and prices continue to rebound. The company's production is being appropriately adjusted based on sales orders.
Limin GroupLtd's (SZSE:002734) Anemic Earnings Might Be Worse Than You Think
Limin Group (002734.SZ) has repurchased 3.8308% of its shares, with an approximate cost of 0.1 billion yuan.
Limin Group (002734.SZ) announced that, as of August 31, 2024, the company has repurchased special...
What You Can Learn From Limin Group Co.,Ltd.'s (SZSE:002734) P/ENo Data
No Data
